Drug Safety Update
admin August 15th, 2007
The MHRA have published the first issue of the replacement for Current Problems in Pharmacovigilance, Drug Safety Update. Drug Safety Update is planned to be a monthly publication, which will mean that the MHRA will be providing a much higher rate of publications than in previous years. Hopefully this service will be of use to practitioners. The MHRA are also asking for feedback about their new publication via a web survey – so do let them know what you like and how it might be improved.
The first issue includes information about:
- Gadolinium-containing MRI contrast agents: nephrogenic systemic fibrosis
- Cabergoline: cardiovalvulopathy
- Antidepressants: suicidal behaviour
- Yellow Card scheme: reporting trends and latest data
- Smoking-cessation aids
- Isotretinoin for severe acne
- Extraneal and products that contain (or are metabolised to) maltose, xylose, or galactose: false glucose reading
- α1-adrenoreceptor antagonists and intraoperative floppy iris syndrome
- Linezolid: restriction of indication
- Dopamine agonists and pathological gambling, increased libido, and hypersexuality